MIAMI & TORONTO--(BUSINESS WIRE)--Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to ...

Good Manufacturing Practice (GMP) compliance in biologics contract manufacturing underpins product safety, efficacy, and ...

Why it matters: Peptides are critical for biomedical research, but poor sourcing can compromise results, waste resources, and risk regulatory violations. What’s the process: A structured workflow ...

Flora’s newly established Flora Lab division is currently selling its portfolio of over 190 products across 1,500+ distribution channels. TORONTO,, May 19, 2021 (GLOBE NEWSWIRE) -- Flora Growth Corp. ...

BOSTON--(BUSINESS WIRE)--LabMinds ®, Inc., a pioneer in automation for solution preparation in life sciences, today announced that the Revo has been approved for use in a Good Manufacturing Practice ...

The US Food and Drug Administration (FDA) has cited a medical device manufacturer and a contract drug testing laboratory for violations of current good manufacturing practices (CGMP). Additionally, ...

CRISPR-Cas9 is one of the most commonly leveraged non-viral editing tools to engineer cells for therapeutics applications. It is a nuclease-based genome editing system which has seen exponential ...

Extracellular vesicles (EVs) derived from mesenchymal stromal cells are advancing regenerative medicine and drug delivery, but their fragility and heterogeneity complicate purification and scale-up.

Flora Lab is acknowledged for its quality procedures which are now in line with global pharmaceutical companies after it receives GMP certification from INVIMA to manufacture cosmetics products ...